Abstract
Objective To investigate the change of epidermal growth factor receptor/protein kinase B (EGFR/AKT) signaling pathway in the generation of tamoxifen (TAM) resistant MCF-7 breast cancer cells and the impact on the tumor cell cycle by suppressing EGFR/AKT signaling pathway.Methods The TAM-R was derived from the wild type MCF-7 breast cancer cells continuously exposed to 1 × 10-7 nmol/L 4-hydroxy tamoxifen for 6 months. EGFR mRNA and p-AKT were detected by using fluorescent quantitation reverse transcription-polymerase chain reaction (fqRT-PCR) and Western blotting,respectively.Cell cycle was tested by flow cytometry.Results The expression levels of EGFR mRNA and p-AKT protein in TAM-R cells were higher (P＜0.05) than those in MCF-7 cells.lnhibitors,ZD1839 and SH-6,suppressed the expression of p-AKT and the proliferation of TAM-R cells significantly.Conclusion The activation of EGFR/AKT signaling pathway may provide other growth signal,not estrogen,in tamoxifen resistant MCF-7 cells. Key words: Epidermal growth factor receptor; Protein kinase B; Tamoxifen; Drug resistance; Breast carcinoma
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
